Showing results (431-440 of 458) with videos related to

Sort By:
Pageof 46
Journal of the National Cancer Institute|February 25, 2020
Evaluation of Durability of a Single Dose of the Bivalent HPV Vaccine: The CVT TrialAimée R Kreimer, Joshua N Sampson, Carolina Porras, et al.
The Lancet. Oncology|December 3, 2020
Efficacy of the bivalent HPV vaccine against HPV 16/18-associated precancer: long-term follow-up results from the Costa Rica Vaccine TrialCarolina Porras, Sabrina H Tsang, Rolando Herrero, et al.
Scientific Reports|February 21, 2025
Generalizable deep neural networks for image quality classification of cervical imagesSyed Rakin Ahmed, Brian Befano, Didem Egemen, et al.
Journal of the National Cancer Institute|May 31, 2022
Performance of Cervical Screening a Decade Following HPV Vaccination: The Costa Rica Vaccine TrialShang-Ying Hu, Aimée R Kreimer, Carolina Porras, et al.
Journal of Lower Genital Tract Disease|March 7, 2022
Contribution of Etiologic Cofactors to CIN3+ Risk Among Women With Human Papillomavirus-Positive Screening Test ResultsMaria Demarco, Didem Egemen, Noorie Hyun, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 11, 2016
Population-Based Precision Cancer Screening: A Symposium on Evidence, Epidemiology, and Next StepsPamela M Marcus, Nora Pashayan, Timothy R Church, et al.
Eclinicalmedicine|June 9, 2020
A study of type-specific HPV natural history and implications for contemporary cervical cancer screening programsMaria Demarco, Noorie Hyun, Olivia Carter-Pokras, et al.
BMC Cancer|May 17, 2018
Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in GuatemalaHong Lou, Eduardo Gharzouzi, Sarita Polo Guerra, et al.
BMC Cancer|March 1, 2020
Correction to: Low-cost HPV testing and the prevalence of cervical infection in asymptomatic populations in GuatemalaHong Lou, Eduardo Gharzouzi, Sarita Polo Guerra, et al.
Pageof 46